154 related articles for article (PubMed ID: 17484284)
1. Influence of water soluble polymers on hydroxypropyl-beta-cyclodextrin complexation of rofecoxib.
Singh I; Aboul-Enein HY
Pharmazie; 2007 Apr; 62(4):284-6. PubMed ID: 17484284
[TBL] [Abstract][Full Text] [Related]
2. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
4. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.
Chowdary KP; Srinivas SV
AAPS PharmSciTech; 2006 Sep; 7(3):79. PubMed ID: 17025259
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
Gundogdu E; Koksal C; Karasulu E
Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
[TBL] [Abstract][Full Text] [Related]
6. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
Jablan J; Szalontai G; Jug M
J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
[TBL] [Abstract][Full Text] [Related]
8. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
9. Development and pharmacological evaluation of cyclodextrin complexes of etoricoxib.
Singh I; Kumar P; Pahuja S; Tung V; Arora S
Acta Pol Pharm; 2011; 68(2):279-84. PubMed ID: 21485302
[TBL] [Abstract][Full Text] [Related]
10. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
Aggarwal S; Singh PN; Mishra B
Pharmazie; 2002 Mar; 57(3):191-3. PubMed ID: 11933849
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of mucoadhesive buccal patches of flurbiprofen.
Mishra SK; Garud N; Singh R
Acta Pol Pharm; 2011; 68(6):955-64. PubMed ID: 22125962
[TBL] [Abstract][Full Text] [Related]
12. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
Rawat S; Jain SK
Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
[TBL] [Abstract][Full Text] [Related]
13. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hupu gum for its carrier property in the design and evaluation of solid mixtures of poorly water soluble drug - rofecoxib.
Vadlamudi HC; Raju YP; Asuntha G; Nair R; Murthy KV; Vulava J
Curr Drug Deliv; 2014; 11(1):62-71. PubMed ID: 24783235
[TBL] [Abstract][Full Text] [Related]
15. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
16. Solubility and dissolution improvement of Rofecoxib using solid dispersion technique.
Rahamathulla M; Hv G; Rathod N
Pak J Pharm Sci; 2008 Oct; 21(4):350-5. PubMed ID: 18930854
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
18. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
19. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
20. Influence of beta-cyclodextrin complexation on glipizide release from hydroxypropyl methylcellulose matrix tablets.
Shivakumar HN; Desai BG; Pandya S; Karki SS
PDA J Pharm Sci Technol; 2007; 61(6):472-91. PubMed ID: 18410048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
